0
Halozyme Therapeutics, Inc.
- 201-500 Employees
- Based in San Diego, California
Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company's product portfolio is primarily based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix.
Halozyme Therapeutics, Inc.
Most Recent Responsibility Report
Halozyme Therapeutics, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Archived Responsibility Reports
-
2022 Environmental, Social & Governance Report View Environmental, Social & Governance Report Download -
2021 Environmental, Social & Governance Report View Environmental, Social & Governance Report Download
Our service enables potential investors to review the most recent and archived Halozyme Therapeutics, Inc. Sustainability Report, Halozyme Therapeutics, Inc. Corporate Social Responsibility Report, Halozyme Therapeutics, Inc. CSR Report, Halozyme Therapeutics, Inc. Corporate Responsibility, Halozyme Therapeutics, Inc. CR Report, Halozyme Therapeutics, Inc. Citizenship Report, Halozyme Therapeutics, Inc. ESG Report, and Halozyme Therapeutics, Inc. Environmental Report online.